Shares of the Hong Kong-based WuXi AppTec Co. (HK:2359) dropped sharply after the U.S. House of Representatives passed a ...

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in ...

(Bloomberg) -- WuXi AppTec Co. generated 65% of its 2023 sales from the US, revenue that’s under threat by American political efforts to cut ties with Chinese biotechnology companies. The US ...

The Biotechnology Innovation Organization (BIO) has said it is parting company with Wuxi AppTec, while voicing support for US legislation that would block Chinese biotechs from federal funding and ...

Shares in WuXi Biologics and WuXi AppTec have tracked up after the BIOSECURE Act – which could have profound effects on their businesses in the US – was omitted from legislation due to be ...

SHANGHAI, Sept. 1, 2024 /PRNewswire/ -- WuXi AppTec, a global company that provides a broad portfolio of R&D and manufacturing services to enable companies in the pharmaceutical and life science ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Technologycategory US Senate bill targeting China's BGI, WuXi AppTec moves forward March 7, 2024 Technologycategory U.S. Senate committee approves bill that could restrict Chinese biotech March 6 ...

WuXi AppTec Co., Ltd., an investment holding company, provides research and manufacturing services to discover, develop, and manufacture spectrum for small molecule drugs and advanced therapies in ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...